ENO1 promotes antitumor immunity by destabilizing PD-L1 in NSCLC.
作者信息
Zhang Chunyi, Zhang Kunpeng, Gu Jie, Ge Di
机构信息
Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Department of Chest Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
出版信息
Cell Mol Immunol. 2021 Aug;18(8):2045-2047. doi: 10.1038/s41423-021-00710-y. Epub 2021 Jun 7.
Abstract
摘要
相似文献
1
ENO1 promotes antitumor immunity by destabilizing PD-L1 in NSCLC.
Cell Mol Immunol. 2021 Aug;18(8):2045-2047. doi: 10.1038/s41423-021-00710-y. Epub 2021 Jun 7.
2
Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
J Hematol Oncol. 2015 Mar 8;8:22. doi: 10.1186/s13045-015-0117-5.
3
Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Oncotarget. 2017 May 30;8(22):36664-36673. doi: 10.18632/oncotarget.17067.
4
Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma.
Oncogene. 2020 Mar;39(13):2786-2796. doi: 10.1038/s41388-020-1172-0. Epub 2020 Feb 5.
5
[ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients].
Zhongguo Fei Ai Za Zhi. 2010 Dec;13(12):1089-93. doi: 10.3779/j.issn.1009-3419.2010.12.02.
6
Proteomic analysis of secreted proteins of non-small cell lung cancer.
Ai Zheng. 2006 Nov;25(11):1361-7.
7
Non-small cell lung carcinomas with a minor sarcomatoid component and pleomorphic carcinomas are associated with high expression of programmed death ligand 1.
Pathol Res Pract. 2020 Dec;216(12):153238. doi: 10.1016/j.prp.2020.153238. Epub 2020 Oct 2.
8
Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden.
Lung Cancer. 2019 Dec;138:35-42. doi: 10.1016/j.lungcan.2019.10.009. Epub 2019 Oct 13.
9
Anti-α-enolase is a prognostic marker in postoperative lung cancer patients.
Oncotarget. 2015 Oct 27;6(33):35073-86. doi: 10.18632/oncotarget.5316.
10
Ubiquitin C-terminal hydrolase L1 promotes expression of programmed cell death-ligand 1 in non-small-cell lung cancer cells.
Cancer Sci. 2020 Sep;111(9):3174-3183. doi: 10.1111/cas.14529. Epub 2020 Jul 6.
引用本文的文献
1
Alpha-enolase promotes progression of acute myeloid leukemia via MAPK/ERK signaling pathway.
Blood Sci. 2025 Aug 11;7(3):e00246. doi: 10.1097/BS9.0000000000000246. eCollection 2025 Sep.
2
Immunomodulatory behavior of CircRNAs in tumor microenvironment.
Oncol Res. 2025 Apr 18;33(5):1105-1119. doi: 10.32604/or.2024.054623. eCollection 2025.
3
ENO1 promotes PDAC progression by inhibiting CD8 T cell infiltration through upregulating PD-L1 expression via HIF-1α signaling.
Transl Oncol. 2025 Feb;52:102261. doi: 10.1016/j.tranon.2024.102261. Epub 2025 Jan 2.
4
Role of ENO1 and its targeted therapy in tumors.
J Transl Med. 2024 Nov 14;22(1):1025. doi: 10.1186/s12967-024-05847-8.
5
O-GlcNAcylation of enolase 1 serves as a dual regulator of aerobic glycolysis and immune evasion in colorectal cancer.
Proc Natl Acad Sci U S A. 2024 Oct 29;121(44):e2408354121. doi: 10.1073/pnas.2408354121. Epub 2024 Oct 24.
6
Targeting MYC at the intersection between cancer metabolism and oncoimmunology.
Front Immunol. 2024 Feb 8;15:1324045. doi: 10.3389/fimmu.2024.1324045. eCollection 2024.
7
Beyond , emerging roles and targeting strategies of other enolases in cancers.
Mol Ther Oncolytics. 2023 Nov 10;31:100750. doi: 10.1016/j.omto.2023.100750. eCollection 2023 Dec 19.
8
Association of Enolase-1 with Prognosis and Immune Infiltration in Breast Cancer by Clinical Stage.
J Inflamm Res. 2023 Feb 7;16:493-503. doi: 10.2147/JIR.S396321. eCollection 2023.
9
ENO1 Promotes OSCC Migration and Invasion by Orchestrating IL-6 Secretion from Macrophages via a Positive Feedback Loop.
Int J Mol Sci. 2023 Jan 1;24(1):737. doi: 10.3390/ijms24010737.
10
BIRC5 Modulates PD-L1 Expression and Immune Infiltration in Lung Adenocarcinoma.
J Cancer. 2022 Aug 21;13(10):3140-3150. doi: 10.7150/jca.69236. eCollection 2022.
Zotero 插件